NCT00430638 - A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension | Biotech Hunter

Enrollment

278

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions

Hypertension

Interventions

DRUG

olmesartan medoxomil + hydrochlorothiazide, if necessary

olmesartan medoxomil + hydrochlorothiazide, if necessary. Oral tablets administered for once daily for 12 weeks

DRUG

Placebo

Oral tablets administered for once daily for 12 weeks

Trial Locations (29)

Unknown

Birmingham

Mobile

Muscle Shoals

Searcy

Carmichael

Spring Valley

Coral Gables

Deerfield Beach

DeLand

Fort Lauderdale

Hialeah

Hollywood

Pembroke Pines

Chicago

Elizabeth

Winston-Salem

Cincinnati

Oklahoma City

Eugene

Downingtown

Charleston

Nashville

New Tazewell

Colleyville

San Antonio

Murray

Manassas

Olympia

Madison